Concepts (196)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mannosyltransferases | 5 | 2018 | 19 | 1.240 |
Why?
|
Endothelial Cells | 4 | 2022 | 296 | 0.820 |
Why?
|
Neovascularization, Pathologic | 5 | 2018 | 122 | 0.670 |
Why?
|
Tunicamycin | 6 | 2022 | 23 | 0.630 |
Why?
|
Breast Neoplasms | 4 | 2022 | 1426 | 0.580 |
Why?
|
Cell Proliferation | 4 | 2015 | 1149 | 0.400 |
Why?
|
Factor VIII | 1 | 2011 | 11 | 0.400 |
Why?
|
Glycoproteins | 1 | 2011 | 100 | 0.370 |
Why?
|
Adrenal Glands | 1 | 2009 | 17 | 0.350 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2009 | 160 | 0.320 |
Why?
|
Unfolded Protein Response | 2 | 2022 | 17 | 0.320 |
Why?
|
Cell Movement | 1 | 2011 | 545 | 0.300 |
Why?
|
Heat-Shock Proteins | 2 | 2018 | 51 | 0.260 |
Why?
|
Gene Expression Regulation, Fungal | 1 | 2004 | 72 | 0.250 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 70 | 0.250 |
Why?
|
Saccharomyces cerevisiae | 1 | 2004 | 193 | 0.230 |
Why?
|
Animals | 14 | 2022 | 14307 | 0.220 |
Why?
|
Gene Expression Regulation | 1 | 2008 | 968 | 0.220 |
Why?
|
Cloning, Molecular | 3 | 2009 | 310 | 0.220 |
Why?
|
Up-Regulation | 1 | 2004 | 490 | 0.210 |
Why?
|
Glycosylation | 4 | 2018 | 92 | 0.210 |
Why?
|
Phosphorylation | 4 | 2015 | 878 | 0.210 |
Why?
|
Cattle | 3 | 2011 | 472 | 0.190 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 2 | 2011 | 16 | 0.180 |
Why?
|
Viral Tail Proteins | 1 | 1999 | 2 | 0.180 |
Why?
|
Bacteriophage P22 | 1 | 1999 | 6 | 0.180 |
Why?
|
Neovascularization, Physiologic | 2 | 2011 | 70 | 0.180 |
Why?
|
Mice | 8 | 2022 | 5668 | 0.170 |
Why?
|
Protein Folding | 1 | 1999 | 121 | 0.170 |
Why?
|
Cells, Cultured | 4 | 2011 | 1442 | 0.160 |
Why?
|
Quality of Life | 1 | 2022 | 459 | 0.160 |
Why?
|
Myocardial Reperfusion | 1 | 2017 | 10 | 0.150 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2018 | 70 | 0.150 |
Why?
|
Cardiology | 1 | 2017 | 16 | 0.150 |
Why?
|
Societies, Medical | 1 | 2017 | 62 | 0.150 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2009 | 195 | 0.150 |
Why?
|
Protein Processing, Post-Translational | 1 | 2018 | 162 | 0.150 |
Why?
|
Disease Management | 1 | 2017 | 61 | 0.150 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2015 | 242 | 0.150 |
Why?
|
Humans | 20 | 2022 | 34853 | 0.140 |
Why?
|
DNA, Complementary | 2 | 2008 | 175 | 0.140 |
Why?
|
Cyclic AMP | 2 | 2008 | 125 | 0.140 |
Why?
|
Transferases (Other Substituted Phosphate Groups) | 1 | 2015 | 6 | 0.130 |
Why?
|
Amino Acid Sequence | 3 | 2017 | 1124 | 0.120 |
Why?
|
Cell Cycle | 2 | 2018 | 309 | 0.120 |
Why?
|
Insulin | 2 | 2011 | 224 | 0.120 |
Why?
|
Dolichol Phosphates | 1 | 1992 | 8 | 0.110 |
Why?
|
Intracellular Membranes | 1 | 1992 | 34 | 0.110 |
Why?
|
Potassium | 2 | 2007 | 110 | 0.110 |
Why?
|
Endoplasmic Reticulum | 1 | 1992 | 101 | 0.110 |
Why?
|
Hemophilia A | 1 | 2011 | 4 | 0.100 |
Why?
|
Asparagine | 1 | 2011 | 8 | 0.100 |
Why?
|
Antibodies, Monoclonal | 1 | 1992 | 282 | 0.100 |
Why?
|
Mice, Nude | 3 | 2018 | 323 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2011 | 148 | 0.090 |
Why?
|
Female | 9 | 2022 | 19873 | 0.090 |
Why?
|
Protein Structure, Tertiary | 1 | 2011 | 383 | 0.090 |
Why?
|
Sequence Alignment | 1 | 2009 | 257 | 0.080 |
Why?
|
Mice, Inbred BALB C | 3 | 2018 | 649 | 0.080 |
Why?
|
G1 Phase | 1 | 2008 | 32 | 0.080 |
Why?
|
Mutation | 3 | 2004 | 1023 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 240 | 0.080 |
Why?
|
Time Factors | 4 | 2015 | 1681 | 0.080 |
Why?
|
Angina Pectoris | 2 | 1984 | 18 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 984 | 0.080 |
Why?
|
Base Sequence | 1 | 2009 | 932 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2004 | 168 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2008 | 392 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2008 | 200 | 0.070 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2007 | 58 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 2 | 1979 | 33 | 0.070 |
Why?
|
Kinetics | 2 | 2004 | 650 | 0.070 |
Why?
|
Electrocardiography | 3 | 1979 | 154 | 0.070 |
Why?
|
Glutamic Acid | 1 | 2007 | 115 | 0.070 |
Why?
|
Recombinant Proteins | 2 | 2004 | 485 | 0.070 |
Why?
|
Interferon Type I | 1 | 1985 | 17 | 0.070 |
Why?
|
Endoribonucleases | 1 | 1985 | 23 | 0.070 |
Why?
|
Receptors, Muscarinic | 1 | 2005 | 16 | 0.070 |
Why?
|
Guanosine Diphosphate | 1 | 2004 | 11 | 0.070 |
Why?
|
Astrocytes | 1 | 2007 | 203 | 0.070 |
Why?
|
Phosphoserine | 1 | 2004 | 18 | 0.060 |
Why?
|
Cerebral Cortex | 1 | 2007 | 274 | 0.060 |
Why?
|
Simplexvirus | 1 | 1984 | 10 | 0.060 |
Why?
|
Mannose | 1 | 2004 | 25 | 0.060 |
Why?
|
Down-Regulation | 1 | 2007 | 420 | 0.060 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 1984 | 18 | 0.060 |
Why?
|
Cnidarian Venoms | 1 | 2005 | 23 | 0.060 |
Why?
|
Spasm | 1 | 1984 | 1 | 0.060 |
Why?
|
Angina, Unstable | 1 | 1984 | 8 | 0.060 |
Why?
|
Serine | 1 | 2004 | 72 | 0.060 |
Why?
|
Retinal Vessels | 1 | 1984 | 24 | 0.060 |
Why?
|
Immunoblotting | 1 | 2004 | 170 | 0.060 |
Why?
|
Genetic Vectors | 1 | 2004 | 154 | 0.060 |
Why?
|
Catalysis | 1 | 2004 | 162 | 0.060 |
Why?
|
Escherichia coli | 2 | 2004 | 436 | 0.060 |
Why?
|
Protein Binding | 2 | 2004 | 913 | 0.060 |
Why?
|
Plasmids | 1 | 2004 | 233 | 0.060 |
Why?
|
DNA Replication | 1 | 1984 | 148 | 0.060 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2015 | 31 | 0.060 |
Why?
|
DNA, Viral | 2 | 1999 | 295 | 0.060 |
Why?
|
Signal Transduction | 1 | 2011 | 1802 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 1979 | 221 | 0.050 |
Why?
|
Protein Conformation | 2 | 2001 | 350 | 0.050 |
Why?
|
Conotoxins | 1 | 2001 | 18 | 0.050 |
Why?
|
Apoptosis | 1 | 2008 | 1317 | 0.050 |
Why?
|
Receptors, Nicotinic | 1 | 2001 | 91 | 0.050 |
Why?
|
Syncope | 1 | 1979 | 3 | 0.050 |
Why?
|
Hydrolysis | 1 | 1999 | 86 | 0.040 |
Why?
|
Salmonella typhimurium | 1 | 1999 | 40 | 0.040 |
Why?
|
India | 3 | 2017 | 82 | 0.040 |
Why?
|
Coronary Disease | 1 | 1979 | 113 | 0.040 |
Why?
|
Amino Acids | 1 | 1999 | 139 | 0.040 |
Why?
|
Cell Line | 3 | 2015 | 1289 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 1033 | 0.040 |
Why?
|
Resuscitation | 1 | 1977 | 17 | 0.040 |
Why?
|
Biocatalysis | 1 | 2017 | 27 | 0.040 |
Why?
|
Glucose | 1 | 1979 | 217 | 0.040 |
Why?
|
Health | 1 | 2017 | 28 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 19 | 0.030 |
Why?
|
Tumor Burden | 1 | 2015 | 79 | 0.030 |
Why?
|
DNA Fragmentation | 1 | 2015 | 91 | 0.030 |
Why?
|
Spectrum Analysis, Raman | 1 | 2015 | 84 | 0.030 |
Why?
|
Neoplasm Transplantation | 2 | 2011 | 114 | 0.030 |
Why?
|
Carbohydrate Sequence | 1 | 1992 | 21 | 0.030 |
Why?
|
Hybridomas | 1 | 1992 | 28 | 0.030 |
Why?
|
Lipopeptides | 1 | 1992 | 20 | 0.030 |
Why?
|
Pacemaker, Artificial | 1 | 1973 | 19 | 0.030 |
Why?
|
Oligopeptides | 1 | 1992 | 97 | 0.030 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 87 | 0.030 |
Why?
|
Thrombospondin 1 | 1 | 2011 | 22 | 0.030 |
Why?
|
Immunohistochemistry | 1 | 1992 | 859 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 1992 | 1490 | 0.020 |
Why?
|
Rats | 2 | 2007 | 3261 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 2128 | 0.020 |
Why?
|
Barium | 1 | 2007 | 15 | 0.020 |
Why?
|
Potassium Channel Blockers | 1 | 2007 | 30 | 0.020 |
Why?
|
Antigens, Viral, Tumor | 1 | 1986 | 8 | 0.020 |
Why?
|
Oncogene Proteins, Viral | 1 | 1986 | 25 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 1986 | 36 | 0.020 |
Why?
|
Simian virus 40 | 1 | 1986 | 43 | 0.020 |
Why?
|
Patch-Clamp Techniques | 1 | 2007 | 214 | 0.020 |
Why?
|
Membrane Potentials | 1 | 2007 | 213 | 0.020 |
Why?
|
RNA Interference | 1 | 2007 | 225 | 0.020 |
Why?
|
Animals, Newborn | 1 | 2007 | 323 | 0.020 |
Why?
|
Adams-Stokes Syndrome | 1 | 1965 | 1 | 0.020 |
Why?
|
Heart Block | 1 | 1965 | 2 | 0.020 |
Why?
|
Homeostasis | 1 | 2007 | 172 | 0.020 |
Why?
|
KB Cells | 1 | 1985 | 7 | 0.020 |
Why?
|
Heart Arrest | 2 | 1977 | 32 | 0.020 |
Why?
|
Endomyocardial Fibrosis | 1 | 1965 | 2 | 0.020 |
Why?
|
Scyphozoa | 1 | 2005 | 3 | 0.020 |
Why?
|
Deficiency Diseases | 1 | 1965 | 4 | 0.020 |
Why?
|
Pathology | 1 | 1965 | 7 | 0.020 |
Why?
|
Carcinoma, Ehrlich Tumor | 1 | 1985 | 17 | 0.020 |
Why?
|
Enzyme Induction | 1 | 1984 | 48 | 0.020 |
Why?
|
Cell Membrane | 1 | 2007 | 360 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 1965 | 55 | 0.020 |
Why?
|
Hela Cells | 1 | 1985 | 344 | 0.020 |
Why?
|
Acenocoumarol | 1 | 1963 | 1 | 0.010 |
Why?
|
Prothrombin | 1 | 1963 | 1 | 0.010 |
Why?
|
Male | 6 | 2005 | 18870 | 0.010 |
Why?
|
Kidney | 1 | 1985 | 322 | 0.010 |
Why?
|
Anticoagulants | 1 | 1963 | 97 | 0.010 |
Why?
|
Torpedo | 1 | 2001 | 41 | 0.010 |
Why?
|
Osmolar Concentration | 1 | 2001 | 55 | 0.010 |
Why?
|
Quaternary Ammonium Compounds | 1 | 2001 | 31 | 0.010 |
Why?
|
Binding, Competitive | 1 | 2001 | 103 | 0.010 |
Why?
|
Static Electricity | 1 | 2001 | 75 | 0.010 |
Why?
|
Middle Aged | 4 | 1979 | 9642 | 0.010 |
Why?
|
Lysine | 1 | 2001 | 104 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2005 | 1534 | 0.010 |
Why?
|
Puerto Rico | 1 | 2005 | 1352 | 0.010 |
Why?
|
Syndrome | 1 | 1979 | 72 | 0.010 |
Why?
|
Binding Sites | 1 | 2001 | 597 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 1979 | 12 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1979 | 9 | 0.010 |
Why?
|
Liver Function Tests | 1 | 1958 | 18 | 0.010 |
Why?
|
Acute Disease | 1 | 1979 | 141 | 0.010 |
Why?
|
Adult | 3 | 1984 | 11034 | 0.010 |
Why?
|
Brain | 1 | 2005 | 1268 | 0.010 |
Why?
|
Liver | 1 | 1958 | 447 | 0.010 |
Why?
|
Heart Failure | 1 | 1958 | 230 | 0.010 |
Why?
|
Aged | 2 | 1979 | 6448 | 0.010 |
Why?
|
Thorax | 1 | 1973 | 5 | 0.010 |
Why?
|
Electrodes, Implanted | 1 | 1973 | 16 | 0.010 |
Why?
|
Fibrosarcoma | 1 | 1986 | 7 | 0.000 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1986 | 13 | 0.000 |
Why?
|
Clone Cells | 1 | 1986 | 46 | 0.000 |
Why?
|
Cell Transformation, Viral | 1 | 1986 | 29 | 0.000 |
Why?
|
Recombination, Genetic | 1 | 1986 | 90 | 0.000 |
Why?
|
Cell Transformation, Neoplastic | 1 | 1986 | 166 | 0.000 |
Why?
|
Child, Preschool | 1 | 1965 | 1318 | 0.000 |
Why?
|
Adolescent | 1 | 1965 | 5035 | 0.000 |
Why?
|
Age Factors | 1 | 1971 | 1007 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1971 | 1003 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1971 | 1961 | 0.000 |
Why?
|